Research Topics
| Penina HaberSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
| Collaborators
|
Detail Information
Publications
Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safetyPenina Haber
Immunization Safety Office, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Mail Stop D 26, 1600 Clifton Rd, Atlanta, GA 30333, USA
Pediatrics 127:S39-44. 2011....
An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: more than intussusception alone?Penina Haber
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Pediatrics 113:e353-9. 2004....- Guillain-Barré syndrome following influenza vaccinationPenina Haber
Immunization Safety Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
JAMA 292:2478-81. 2004..Guillain-Barre syndrome remains the most frequent neurological condition reported after influenza vaccination to the Vaccine Adverse Events Reporting System (VAERS) since its inception in 1990... - Vaccines and Guillain-Barré syndromePenina Haber
Immunization Safety Office, Office of the Chief Science Officer, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Drug Saf 32:309-23. 2009..However, the benefit of vaccines in preventing disease and decreasing morbidity and mortality, particularly for influenza, needs to be weighed against the potential risk of GBS... - Postlicensure safety surveillance for high-dose trivalent inactivated influenza vaccine in the Vaccine Adverse Event Reporting System, 1 July 2010-31 December 2010Pedro L Moro
Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Clin Infect Dis 54:1608-14. 2012..We characterized clinical patterns of reports to the Vaccine Adverse Event Reporting System (VAERS) among older adults who received TIV-HD... - Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007Penina Haber
Centers for Disease Control and Prevention, National Center for Immunizations and Respiratory Diseases, 1600 Clifton Rd, MS A 47, Atlanta, GA 30333, USA
Pediatrics 121:1206-12. 2008..Although the new rotavirus vaccine (RotaTeq; Merck, West Point, PA) introduced in 2006 was not associated with intussusception in prelicensure trials, additional monitoring is important to ensure a complete safety profile... - Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003Armenak Asatryan
Science Applications International Corporation and Emory University School of Medicine, Atlanta, GA, USA
Vaccine 26:1166-72. 2008..Thus, HL following MMCV has been reported in the literature and to the VAERS. Further studies are needed to better understand if there is a causal relationship between MMCV and HL... - Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoringClaudia Vellozzi
Immunization Safety Office ISO, Office of the Chief Science Officer OCSO, Centers for Disease Control and Prevention, Atlanta, GA, United States
Vaccine 27:2114-20. 2009..No new safety concerns emerged after our review of 15 years of post-licensure surveillance data. These findings provide useful information if pandemic vaccine is rapidly distributed and pre-licensure data are limited... - Death and serious illness following influenza vaccination: a multidisciplinary investigationAlison Rue-Cover
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Immunization Safety Office ISO, Division of Healthcare Quality Promotion, Atlanta, GA 30333, USA
Pharmacoepidemiol Drug Saf 18:504-11. 2009..All had received vaccine from the same lot (Lot A)... - Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009Pedro L Moro
Immunization Safety Office, Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Am J Obstet Gynecol 204:146.e1-7. 2011..The objective of the study was to characterize reports to the Vaccine Adverse Event Reporting System (VAERS) in pregnant women who received seasonal influenza vaccines to assess for potential vaccine safety concerns... - Intussusception and rotavirus vaccination: a review of the available evidenceManish M Patel
Viral Gastroenteritis Section, MS A47, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Expert Rev Vaccines 8:1555-64. 2009..We review these safety data for the new vaccines and for Rotashield to provide background information relevant for considering age recommendations for rotavirus vaccination... - Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010Pedro L Moro
Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Vaccine 29:9404-8. 2011..Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine was not licensed for use in adults aged ≥65 years due to lack of sufficient efficacy and safety data... - Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010Claudia Vellozzi
Immunization Safety Office, Division of Health Care Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Vaccine 28:7248-55. 2010..Death, Guillain-Barré syndrome and anaphylaxis reports after 2009-H1N1 vaccination were rare (each <2 per million doses administered)... 
Monitoring vaccine safety during an influenza pandemicJohn Iskander
Immunization Safety Office, Office of the Chief Science Officer, Office of the Director, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Yale J Biol Med 78:265-75. 2005..Advance planning and the use of available technologic solutions are needed to respond to the scientific and logistic challenges involved in safely implementing mass vaccination during a pandemic...- A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001Weigong Zhou
Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Pharmacoepidemiol Drug Saf 13:505-10. 2004..A population-based controlled study is needed to determine whether this association could be causal and to quantify the risk... - Adverse events following administration to pregnant women of influenza A (H1N1) 2009 monovalent vaccine reported to the Vaccine Adverse Event Reporting SystemPedro L Moro
Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
Am J Obstet Gynecol 205:473.e1-9. 2011.... - Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant womenYenlik A Zheteyeva
Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, USA
Am J Obstet Gynecol 207:59.e1-7. 2012..We sought to characterize reports to the Vaccine Adverse Event Reporting System (VAERS) of pregnant women who received tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap)... - Adverse event reports following vaccination for Lyme disease: December 1998-July 2000Sarah L Lathrop
Centers for Disease Control and Prevention, Epidemic Intelligence Service, Atlanta, GA 30333, USA
Vaccine 20:1603-8. 2002.... - Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007Anthony E Fiore
Influenza Division, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, GA 30333, USA
MMWR Recomm Rep 56:1-54. 2007..Immunization providers should be alert to announcements of recommendation updates and should check the CDC influenza website periodically for additional information... - Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005Sandra S Chaves
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 197:S170-7. 2008..Ongoing safety surveillance and further studies may shed light on some of the hypothesized associations... - Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001Weigong Zhou
Epidemic Intelligence Service Program, Epidemiology Program Office, CDC, USA
MMWR Surveill Summ 52:1-24. 2003..This knowledge facilitates improvement in the safety of vaccines and the vaccination process... - Influenza vaccination and Guillain Barré syndromePenina Haber
Clin Immunol 109:359; author reply 360-1. 2003 - Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003Ann W McMahon
Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, 1401 Rockville Pike, Rockville, Maryland 20852, USA
Pediatrics 115:453-60. 2005..In April 2002, the Advisory Committee on Immunization Practices (ACIP) encouraged providers to vaccinate healthy 6- to 23-month-old infants and children with trivalent influenza vaccine (TIV)... - Letter to the Editor. Guillain-Barré Syndrome(GBS) after vaccination reported to the United States Vaccine Adverse Event Reporting System(VAERS) in 2004Penina Haber
Vaccine 25:8101. 2007 - Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002Elizabeth M Begier
Vaccine Safety Branch, Division of Epidemiology, Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland 20852-1448, USA
Clin Infect Dis 38:771-9. 2004..Nonfatal anaphylaxis was reported after both vaccines. VAERS reports do not indicate any unexpected serious side effects that compromise these vaccines' use for travelers' prophylaxis... - Adverse events reported following live, cold-adapted, intranasal influenza vaccineHector S Izurieta
Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, MD 20852 1448, USA
JAMA 294:2720-5. 2005..Although prelicensure testing involved 20 228 vaccinees, clinical trials were not of sufficient size to detect rare adverse events reliably... - Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997Jenifer C Lloyd
Office of Epidemiology, Utah Department of Health, Bureau for Children with Special Health Care Needs, P O Box 144640, Salt Lake City, UT 84114 4640, USA
Vaccine 21:3746-50. 2003..While reporting rates are lower after TT than Td, rates of reported VAEs after both vaccines are low... - Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)Rafael Harpaz
Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, USA
MMWR Recomm Rep 57:1-30; quiz CE2-4. 2008..Before administration of zoster vaccine, patients do not need to be asked about their history of varicella (chickenpox) or to have serologic testing conducted to determine varicella immunity...